An in-depth look to Contineum Therapeutics, Inc. operating, investing, and financing activities

CTNM free cash flow for Q1 24 is -8.26 M USD. For 2023, CTNM free cash flow was 18.93 M USD and operating cash flow was 19.35 M USD.